NLA Resources
Familial Hypercholesterolemia
19 Resources
Knowledge Center
The National Lipid Association is your destination for the science of lipid medicine. Now, everything we know is in one place.
Familial Hypercholesterolemia
19 Available Resources
Pediatric Hypercholesterolemia
Genetic Testing
S1E2: General Gaps in FH Care
Dr. Alan Browns sits down with Dr. David Davidson to provide insight into the gaps in treatment of patients with…
The Lipid Panel – Familial Hypercholesterolemia
The Palms of Rare Lipid Disorders
Several genetic lipid disorders manifest with physical examination findings in the palms, making it important for lipid specialists to examine…
Familial Hypercholesterolemia Definition & Diagnosis Criteria
Case Study: Type 1 Diabetes, Familial Hypercholesterolemia, and Elevated Lipoprotein(a)
Familial hypercholesterolemia (FH) and type 1 diabetes (T1D) are characterized by significant morbidity and premature mortality. Lipoprotein(a) [Lp(a)], an independent…
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
S2E3: Evinacumab: A new therapeutic option to treat dyslipidemia
Join Dr. Alan Brown and Dr. Robert Rosenson as they discuss evinacumab, a new therapeutic option for treating dyslipidemia.
S2E4: Genetic Variations in Patients with Very High LDL Cholesterol Including Familial Hypercholesterolemia
Dr. Alan Brown sits down with the 2020 Donald Hunninghake, MD, Familial Hypercholesterolemia (FH) Abstract Award winner to discuss genetic…
Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association
Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association
S7E1: Changing the FH Playbook: Diagnosis and Treatment Updates from the NLA
Hosted by Dave Dixon, PharmD, CLS, FNLA, this episode features an in-depth discussion with three key authors of the NLA’s…
Case Study: A Patient with Familial Hypercholesterolemia and Statin-Associated Muscle Effects: Pharmacotherapy and Lifestyle
Atherosclerotic cardiovascular disease (ASCVD) is an umbrella term for atherosclerotic conditions that affect the cardiovascular system, including ischemic heart disease,…
Why is this Small Adult in My Office? How to Identify, Treat, and Advocate for Children with Familial Hypercholesterolemia
Heterozygous familial hypercholesterolemia (HeFH) is an autosomal co-dominant genetic disorder, affecting roughly 1 in 220 people; characterized by lifelong elevated…
Update on Familial Hypercholesterolemia: An Expert Clinical Consensus from the National Lipid Association
Update on Familial Hypercholesterolemia: An Expert Clinical Consensus from the National Lipid Association
S6 Lipid Snippet | Polygenic Risk Score for Coronary Artery Disease Predicts ASCVD in FH
Can genetic scores unlock better outcomes for patients with FH? This special Snippet from our Lipid Insights podcast series dives…
Navigating Barriers in Familial Hypercholesterolemia Journey: A Tale of Resilience and Advocacy
As the physicians employed by a government hospital, we frequently encounter patients facing significant social and financial challenges. This often…
Finding Familial Hypercholesterolemia in the Perinatal Period
Familial hypercholesterolemia (FH) is an autosomal codominant genetic disorder of lipoprotein metabolism associated with disproportionately high levels of lowdensity lipoprotein…
Management of Hypercholesterolemia in Young Women of Childbearing Years and During Pregnancy
JK is a 35-year-old female nonsmoker who first presented to clinical lipidology care after developing angina while breastfeeding her first…
Join the NLA
Become A Member
When you become a member of the NLA, you become part of a collegial multidisciplinary group of leaders dedicated to improving lipid and cardiometabolic health.
